Focus on Life Science businesses

Bayer plans to focus entirely on the Life Science businesses – HealthCare and CropScience – in the future and to float MaterialScience on the stock market as a separate company. This will create a global leader in the Life Sciences with extensive experience in science and innovation and the ability to use this expertise to improve human, animal and plant health.

For a better life
Across the globe, people continue to suffer from severe illnesses for which very few effective, well tolerated treatments are available. Research-driven pharmaceutical companies like Bayer are working on innovations intended to benefit these patients. » more

Promoting health and well-being
With its range of non-prescription and nutritional products, Bayer aims to help people do more for their health and well-being. This not only increases personal quality of life but can also greatly reduce health care costs. » more

Food for the world
Bayer CropScience has an ambitious goal: to find innovative answers to the challenges of the future. In pursuit of that aim, the company spends some €1 billion a year on agricultural research and development designed to help feed the growing global population. » more

Life Sciences
Research at the interface
Scientists at Bayer HealthCare and Bayer CropScience are working on various joint research projects aimed at finding solutions in the fields of health care and nutrition as part of a cross-subgroup initiative to further strengthen Bayer’s innovative capability. » more

High-quality materials
Optimally equipped for the future
Innovative materials such as those produced and constantly improved by Bayer MaterialScience are the driving force behind technological progress. The planned demerger from the Bayer Group is expected to make MaterialScience the fourth-leading chemical company in Europe – and enable it to apply its strengths even more effectively. » more

Last updated: March 17, 2015  Copyright © Bayer AG